DNALite Therapeutics careers

DNALite Therapeutics is making DNA based gene-therapy drugs for the gastrointestinal (GI) tract by leveraging new drug delivery technologies. Our current target is Familial Adenomatous Polyposis (FAP). FAP patients develop colorectal and duodenal cancer at high rates resulting in them living in constant fear and undergoing painful surgeries at a young age (in their teens). Our drug is aimed to remove these surgeries completely.